Latest Breaking News On - Agomab receives - Page 1 : vimarsana.com

Currently, the drug is being evaluated in a phase 1 clinical trial to determine the safety and efficacy in patients.

Philippe wieselPhasei studyAssess safetyHealthy participantsParticipants withAgomab therapeuticsAgomab receivesDrug designationIdiopathic pulmonaryAccessed june